Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Cara Therapeutics Inc. (CARA)

19.51   0.47 (2.47%) 04-25 15:50
Open: 19.24 Pre. Close: 19.04
High: 19.53 Low: 18.64
Volume: 444,744 Market Cap: 772M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 19.345 - 19.423 19.423 - 19.498
Low: 18.181 - 18.265 18.265 - 18.346
Close: 18.902 - 19.037 19.037 - 19.166

Technical analysis

as of: 2019-04-25 3:28:48 PM
Overall:       
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 24.35     One year: 28.44
Support: Support1: 18.67    Support2: 17.32
Resistance: Resistance1: 20.85    Resistance2: 24.35
Pivot: 19.22
Moving Average: MA(5): 18.60     MA(20): 19.30
MA(100): 16.74     MA(250): 17.70
MACD: MACD(12,26): 0.09     Signal(9): 0.23
Stochastic oscillator: %K(14,3): 49.29     %D(3): 36.83
RSI: RSI(14): 53.30
52-week: High: 24.30  Low: 11.50  Change(%): 53.8
Average Vol(K): 3-Month: 66442  10-Days: 81518

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CARA has closed below upper band by 49.6%. Bollinger Bands are 1.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 14 Apr 2019 19:06:57 Z
Better Buy: GW Pharmaceuticals vs. Cara Therapeutics

Thu, 11 Apr 2019 21:06:05 Z
Noteworthy Thursday Option Activity: CARA, IAC, EXPE

Tue, 09 Apr 2019 14:07:59 Z
Why Cara Therapeutics Stock Jumped 15.1% in March

Mon, 08 Apr 2019 15:09:01 Z
3 Top Biotech Stocks to Buy in April

Sun, 07 Apr 2019 20:07:56 Z
3 Top Small-Cap Biotech Stocks for Aggressive Investors

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 39.55
Shares Float (M) 38.10
% Held by Insiders 4.30
% Held by Institutions 86.10
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -2.060
EPS Est. Current Year -1.780
EPS Est. Next Year -1.860
EPS Est. Next Quarter -0.380
Forward EPS -2.180
Book Value (p.s.) 5.760
PEG Ratio
Profit Margin
Operating Margin -574.52
Return on Assets (ttm) -51.4
Return on Equity (ttm) -67.2
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -22.30
Levered Free Cash Flow (M) -10.30

Stock Valuations

P/E -9.33
P/E Growth Ratio 0.01
P/BV 3.34
P/S 2001438080.00
P/CF -34.10

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2014-01-16
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.